期刊文献+

Exendin-4真核表达载体的构建及其在毕赤酵母中的表达 被引量:1

Construction of Exendin-4 Eukaryotic Expression Vector and Its Expression in P. Pastoris
原文传递
导出
摘要 目的:构建Exendin-4基因真核表达载体,并在巴斯德毕赤酵母GS115中进行表达,为大量获得Exendin-4奠定基础。方法:采用重叠聚合酶链反应法扩增出Exendin-4的完整序列,将其亚克隆到表达载体pPIC9K上,得到重组质粒pPIC9K-Exendin-4。重组质粒经SacI线性化后用电穿孔法导入到GS115中,经组氨酸缺陷筛选、G418高拷贝筛选及摇瓶表达筛选,甲醇诱导表达后用凝胶电泳法分析Exendin-4的表达。结果:序列测定结果表明成功地构建了毕赤酵母表达载体,电泳结果证明Exendin-4在毕赤酵母中能高效表达。结论:实现了Exendin-4单体在毕赤酵母中的表达,为Exendin-4的规模化生产奠定了基础。 OBJECTIVE: To construct eukaryotic expression vector of Exendin - 4, and study its expression in P. Pastoris strain GSl15 so as to lay foundation for gaining large quantity of Exendin- 4. METHODS: The whole sequence of Exendin- 4 gene was amplified by overlapping PCR.Then the gene was subcloned into the pPICgK expression vector to obtain recombinant plasmid pPIC9K - Exendin - 4, which was transformed into GSl15 by electroporation after Sac I linearization. Through histidine auxotroph screening, G418 high- copy screening, flask- shaking expression screening, and methanol- induced ex- pression, the expression of Exendin- 4 was analyzed by gel electrophoresis(GE) . RESULTS: The sequencing revealed the successful construction of the expression vector of P.pastoris and the GE results confirmed high expression of Exendin- 4 in P.pastoris. CONCLUSION: The expression of Exendin- 4 monomer in P.pastoris has been achieved and the results laid a foundation for large scale production of Exendin- 4.
出处 《中国药房》 CAS CSCD 北大核心 2009年第22期1707-1709,共3页 China Pharmacy
关键词 EXENDIN-4 毕赤酵母 PPIC9K 真核表达载体 Exendin-4 P. pastoris pPIC9K Eukaryotic expression vector
  • 相关文献

参考文献7

  • 1DeFronzo RA, Ratner RE, Han J, et al. Effects of exenatide (exendin - 4) on glycemic control and weight over 30 weeks in metformin - treated patients with type 2 diabetes[J ] .Diabetes Care, 2005,28(5):1 092.
  • 2Yi LA, Yin XP, Wei DZ, et al. Expression and purication o( exendin- 4 dimer in Eschelichia Coli and its interaction with GLP- 1 receptor in vitro[J].Protein Pep Lett, 2006,13(4) : 823.
  • 3J.萨姆布鲁克,E.F.弗里奇,T.曼尼阿蒂斯.分子克隆实验指南[M].第3版.北京:科学出版社,2002:1316.
  • 4De Leon DD, Crulchlow MF, Ham JY, et al. Role of glucagon - like peptide - 1 in the pathogenesis and treatment of diabetes mellitus[J] . Int J Biochem Cell Biol, 2006,38( 5-- 6) : 845.
  • 5Guerei B, Martin CS. Exenatide: its position in the treatment of type 2 diabetes[J] .Ann Endocrinol, 2008, 69(3) : 201.
  • 6Zhou J, Chu J, Wang YH, et a!. Purification and bioactivity of exendin- 4, a peptide analogue of GLP- 1, expressed in Pichia pastoris [J ].Biotechnol Lett, 2008,30(4) : 651.
  • 7Huang YS, Chen Z, Chen YQ, et al. Preparation and characterization of a novel exendin - 4 human serum albumin fusion protein expressed in Pichia pastoris [J ]. J Pept Sci ,2008,14(5) : 588.

共引文献3

同被引文献21

  • 1Gedulin BR, Nikoulina SE, Smith PA, et al. Exenatide (Exendin-4) improves insulin sensitivity and β-Cell mass in insulin-resistant obese fa/fa zucker rats independent of glycemia and body weight. Endocrinology, 2005, 146(4): 2069-2076.
  • 2Parkes DG, Pittner R, Jodka C, et al. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro. Metabolism, 2001, 50(5): 583-589.
  • 3Tourrel C, Bailbe D, Meile M J, et al. Glucagon-like peptide-1 and Exendin-4 stimulate β-Cell neogenesis newborn rats resulting glucose homeostasis at 50(7): 1562-1570. in streptozotocin-treated in persistently improved adult age. Diabetes, 2001,.
  • 4Kolterman Synthetic OG, Buse Exendin-4 JB, Fineman (Exenatide) MS, et al. significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. J Clin Endocrinol Metab, 2003, 88(7): 3082-3089.
  • 5Mank CM, Moore CX, Jodka CM, et al. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures. Int J Obes, 2006, 30(9): 1332-1340.
  • 6Hansen KB, Vilsboll T, Knop FK. Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes-a review. Diabetes Metab Syndr Obes, 2010, 3: 155-163.
  • 7Akkati S, Sam KG, Tungha G. Emergence of promising therapies in diabetes mellitus. J Clin Pharmacol, 2011, 51(6): 796-804.
  • 8Wang XC, Zu XY, Chen HG, et al. Preparation and purification Exendin-4 from Escherichia coli: China, 200810049811.5. 2009- 11-25.
  • 9Yi L, Yin XP, Wei DZ, et al. Expression and purification of Exendin-4 dimer in Escherichia coli and its interaction with GLP-1 receptor in vitro. Protein Pept Lett, 2006, 13(8): 823-827.
  • 10Yan R, Ding Y, Yang ZY, et al. New method for preparing and expression recombinant Exendin-4: CN, 201010513310.5. 2011-03-30.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部